![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 36, 24707-24717, September 5, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶1
From the
¶Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29401 and the Departments of
Medicine, ||Neuroscience, and
Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425
The sphingolipid ceramide has been implicated in mediating cell death that is accompanied by mitochondrial functional alterations. Moreover, ceramide has been shown to accumulate in mitochondria upon induction of apoptotic processes. In this study, we sought to evaluate the effects of natural, highly hydrophobic long-chain ceramides on mitochondrial function in vitro. Ceramide in a dodecane/ethanol delivery system inhibited the opening of the mitochondrial permeability transition pore (PTP) induced by either oxidative stress, SH group cross-linking, or high Ca2+ load, suggesting that the inhibitory point is at a level at which major PTP regulatory pathways converge. Moreover, ceramide had no effect on well known mitochondrial components that modulate PTP activity, such as cyclophilin D, voltage-dependent anion channel, adenine nucleotide transporter, and ATP synthase. The inhibitory effect of ceramide on PTP was not stereospecific, nor was there a preference for ceramide over dihydroceramide. However, the effect of ceramide on PTP was significantly influenced by the fatty acid moiety chain length. These studies are the first to show that long-chain ceramide can influence PTP at physiologically relevant concentrations, suggesting that it is the only known potent natural inhibitor of PTP. These results suggest a novel mechanism of ceramide regulation of mitochondrial function.
Received for publication, March 6, 2008 , and in revised form, June 3, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grant AG16583 (to L. M. O.), National Institutes of Health Grant P20 RR 17677-04 (to T. I. G.), and National Institutes of Health Grant CO6 RR018823. This work was also supported by Veterans Affairs Merit Awards (to T. I. G. and L. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Medicine, Medical University of South Carolina, 114 Doughty St., POB 250779, Charleston, SC 29425. Tel.: 843-876-5169; Fax: 843-876-5172; E-mail: obeidl{at}musc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |